Phibro Animal Health | PAHC - Operating Expenses


Phibro Animal Health reported $332.36M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Align Technology USD 822.85M 11.8M Dec/2025
ANI Pharmaceuticals USD 217.93M 287.88M Dec/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 129.98M 16.05M Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Canopy Growth CAD 87.2M 6.22M Dec/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Henry Schein USD 3.25B 110M Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Merck USD 10.16B 558M Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Pacira USD 193.68M 27.32M Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 200.95M 6.51M Dec/2025
Supernus Pharmaceuticals USD 197.75M 54.54M Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025